Yuxuan Wang

发表

Detection and localization of surgically resectable cancers with a multi-analyte blood test

Ludmila V. Danilova, J. Vogelstein, S. Hanash, 2018, Science.

Non-invasive detection of bladder cancer through the analysis of driver gene mutations and aneuploidy

J. Ptak, K. Kinzler, B. Vogelstein, 2017, bioRxiv.

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

R. Strausberg, K. Kinzler, B. Vogelstein, 2016, Science Translational Medicine.

Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study

K. Kinzler, P. Gibbs, M. Christie, 2018, Gut.

Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas (Cancer Research (2009) 69, (4036-42))

Yuanjian Feng, Tian-Li Wang, Yuxuan Wang, 2009 .

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

M. Choti, J. Cameron, L. Wood, 2014, Science Translational Medicine.

Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.

J. Ptak, K. Kinzler, B. Vogelstein, 2019, JAMA oncology.

Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers

J. Ptak, K. Kinzler, B. Vogelstein, 2018, Science Translational Medicine.

A combination of molecular markers and clinical features improve the classification of pancreatic cysts.

Jin-Young Jang, Amanda Blackford, Mari Mino-Kenudson, 2015, Gastroenterology.

Efficacy and safety of anti-angiogenesis medicines for advanced soft tissue sarcoma: a meta-analysis

Yuxuan Wang, Yuxi Zhu, X. Dai, 2020, Translational cancer research.

Mechanism of interaction between TM4SF1 and jak2-stat3 signaling pathway in lung cancer cells and expression analysis in non-small cell lung cancer

Yuxuan Wang, Weikang Chen, Lipeng Li, 2020 .

Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study

K. Kinzler, B. Vogelstein, L. Diaz, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The diagnostic value of thyroglobulin in fine-needle aspiration of metastatic lymph nodes in patients with papillary thyroid cancer and its influential factors.

Yuxuan Wang, Chao Jing, Xudong Wang, 2021, Surgical oncology.

Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC).

R. Strausberg, K. Kinzler, B. Vogelstein, 2014 .

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.

J. Ptak, K. Kinzler, B. Vogelstein, 2022, The New England journal of medicine.

High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma

K. Kinzler, B. Vogelstein, N. Papadopoulos, 2016, Virchows Archiv.

Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder

K. Kinzler, B. Vogelstein, N. Papadopoulos, 2017, Virchows Archiv.

Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder.

K. Kinzler, B. Vogelstein, N. Papadopoulos, 2016, Human pathology.

Isaac Kinde Endometrial Cancers Evaluation of DNA from the Papanicolaou Test to Detect Ovarian

James R. Eshleman, Yuxuan Wang, Bert Vogelstein, 2013 .

Pattern and Predictive Factors of Metastasis in Lymph Nodes Posterior to the Right Recurrent Laryngeal Nerve in Papillary Thyroid Carcinoma

Yuxuan Wang, Chao Jing, Jiajia Zhu, 2022, Frontiers in endocrinology.

The potential of circulating tumor DNA (ctDNA) to guide adjuvant chemotherapy decision making in locally advanced rectal cancer (LARC).

K. Kinzler, B. Vogelstein, P. Gibbs, 2017 .

Identifying LATS2 as a prognostic biomarker relevant to immune infiltrates in human esophageal squamous cell carcinoma

Yuxuan Wang, L. Xian, Minqi Zhu, 2022, Frontiers in Genetics.

An improved method to build lung cancer PDX models by surgical resection samples and its association with B7-H3 expression

Yuxuan Wang, Haitao Huang, Biao Zhang, 2019, Translational cancer research.

Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma.

Yuchen Jiao, Yuxuan Wang, Bert Vogelstein, 2012, Cancer discovery.

High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder

K. Kinzler, B. Vogelstein, N. Papadopoulos, 2016, Modern Pathology.

NR4A2 may be a potential diagnostic biomarker for myocardial infarction: A comprehensive bioinformatics analysis and experimental validation

Zhe Zhang, Yuxuan Wang, D. Wei, 2022, Frontiers in Immunology.

Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage II Colon Cancer (DYNAMIC Trial): Statistical Analysis Plan

B. Vogelstein, P. Gibbs, J. Cohen, 2021, medRxiv.

Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord

J. Ptak, K. Kinzler, C. Bettegowda, 2015, Proceedings of the National Academy of Sciences.

Bisulfite-converted duplexes for the strand-specific detection and quantification of rare mutations

K. Kinzler, B. Vogelstein, N. Papadopoulos, 2017, Proceedings of the National Academy of Sciences.

Exomic Sequencing of Four Rare Central Nervous System Tumor Types

Gary L. Gallia, Yuchen Jiao, Yuxuan Wang, 2013, Oncotarget.

Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer.

J. Potash, P. Zandi, L. Wood, 2016, Cancer discovery.

Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas

K. Kinzler, C. Bettegowda, B. Vogelstein, 2015, Science Translational Medicine.

Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers

M. Makary, S. Hanash, Song-Cheol Kim, 2017, Proceedings of the National Academy of Sciences.

TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine.

K. Kinzler, B. Vogelstein, R. Hruban, 2013, Cancer research.

Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer.

J. Ptak, K. Kinzler, B. Vogelstein, 2019, JAMA oncology.

Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors

L. Wood, E. Montgomery, K. Kinzler, 2014, Nature Genetics.

Cancer‐Associated Mutations in Endometriosis without Cancer

L. Wood, K. Kinzler, B. Vogelstein, 2017, The New England journal of medicine.

The potential of circulating tumor DNA (ctDNA) to reshape the design of clinical trials testing adjuvant therapy in patients with early stage cancers.

R. Strausberg, K. Kinzler, B. Vogelstein, 2016 .

Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations.

K. Kinzler, B. Vogelstein, N. Papadopoulos, 2019, Human pathology.

Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy

Ludmila V. Danilova, J. Ptak, K. Kinzler, 2018, eLife.

University of Southern Denmark Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers

J. Ptak, K. Kinzler, B. Vogelstein, 2018 .

A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts

Young Joon Ahn, Elliot K. Fishman, Yuxuan Wang, 2017, J. Am. Medical Informatics Assoc..

Identify AGAP2 as prognostic biomarker in clear cell renal cell carcinoma based on bioinformatics and IHC staining

Yuxuan Wang, Xiaojie Ang, Jiangnan Xu, 2023, Heliyon.

Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies

J. Ptak, K. Kinzler, B. Vogelstein, 2020, International journal of cancer.

Detection of thyroglobulin in fine-needle aspiration for diagnosis of metastatic lateral cervical lymph nodes in papillary thyroid carcinoma: A retrospective study

Yuxuan Wang, Chao Jing, Jiajia Zhu, 2022, Frontiers in Oncology.

Diagnostic potential of tumor DNA from ovarian cyst fluid

K. Kinzler, B. Vogelstein, L. Diaz, 2016, eLife.

Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke

M. Meyerson, J. Derisi, L. Wood, 2015, Head & neck.

Pulmonary Adenofibroma: Clinicopathological and Genetic Analysis of 7 Cases With Literature Review

Yuxuan Wang, P. Zhou, Weiya Wang, 2021, Frontiers in Oncology.

Non-invasive detection of bladder cancer through the analysis of driver gene 1 mutations and aneuploidy 2 3

Nickolas, Natalie, J. Ptak, 2017 .

Yuxuan Wang, Weikang Chen, L. Xian, 2021, Frontiers in Molecular Biosciences.

Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study

J. Ptak, K. Kinzler, B. Vogelstein, 2021, PLoS medicine.

Non-invasive detection of upper tract urothelial carcinomas through the analysis of driver gene mutations and aneuploidy in urine

Ludmila V. Danilova, J. Ptak, K. Kinzler, 2017, bioRxiv.

Detection of Somatic TP53 Mutations in Tampons of Patients With High-Grade Serous Ovarian Cancer

K. Kinzler, B. Vogelstein, L. Diaz, 2014, Obstetrics and gynecology.

Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers

K. Kinzler, C. Bettegowda, B. Vogelstein, 2013, Science Translational Medicine.

Detection of rare mutations, copy number alterations, and methylation in the same template DNA molecules.

J. Ptak, K. Kinzler, C. Bettegowda, 2023, Proceedings of the National Academy of Sciences of the United States of America.

LRP1B mutation is associated with tumor immune microenvironment and progression-free survival in lung adenocarcinoma treated with immune checkpoint inhibitors

Yuxuan Wang, Haitao Huang, Yichao Shi, 2023, Translational lung cancer research.

Development and Validation of a Nomogram based on cell growth-related Biomarkers for Oral Squamous Cell Carcinoma

Yuxuan Wang, Xudong Wang, Yan-sheng Wu, 2021, Journal of Cancer.

The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with nonspecific findings on standard investigations

K. Kinzler, B. Vogelstein, P. Gibbs, 2019, International journal of cancer.

Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy

J. Ptak, K. Kinzler, B. Vogelstein, 2018, eLife.

Serial circulating tumor DNA (ctDNA) analysis as a prognostic marker and a real-time indicator of adjuvant chemotherapy (CT) efficacy in stage III colon cancer (CC).

K. Kinzler, B. Vogelstein, P. Gibbs, 2018 .

Serial circulating tumor DNA (ctDNA) and recurrence risk in patients (pts) with resectable colorectal liver metastasis (CLM).

R. Strausberg, K. Kinzler, B. Vogelstein, 2016 .

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer.

R. Strausberg, K. Kinzler, B. Vogelstein, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid

Christopher M. Jackson, J. Ptak, K. Kinzler, 2022, medRxiv.

PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation

Yuxuan Wang, Qing Yang, Xiao Li, 2023, BMC Cancer.

Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder.

K. Kinzler, B. Vogelstein, N. Papadopoulos, 2016, Human pathology.

Exomic Sequencing of Four Rare Central Nervous System Tumor Types

Zev A. Binder, R. McLendon, L. Wood, 2013, OncoTarget.